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Abstract 
Background: This paper examines the impact of the scale-up of malaria rapid diagnostic tests (RDT) on routine clini-
cal diagnosis procedures for febrile illness in primary healthcare settings in Papua New Guinea.
Methods: Repeat, cross-sectional surveys in randomly selected primary healthcare services were conducted. Surveys 
included passive observation of consecutive febrile case management cases and were completed immediately prior 
to RDT scale-up (2011) and at 12- (2012) and 60-months (2016) post scale-up. The frequency with which specified 
diagnostic questions and procedures were observed to occur, with corresponding 95% CIs, was calculated for febrile 
patients prescribed anti-malarials pre- and post-RDT scale-up and between febrile patients who tested either nega-
tive or positive for malaria infection by RDT (post scale-up only).
Results: A total of 1809 observations from 120 health facilities were completed across the three survey periods of 
which 915 (51%) were prescribed an anti-malarial. The mean number of diagnostic questions and procedures asked 
or performed, leading to anti-malarial prescription, remained consistent pre- and post-RDT scale-up (range 7.4–7.7). 
However, alterations in diagnostic content were evident with the RDT replacing body temperature as the primary 
diagnostic procedure performed (observed in 5.3 and 84.4% of cases, respectively, in 2011 vs. 77.9 and 58.2% of cases 
in 2016). Verbal questioning, especially experience of fever, cough and duration of symptoms, remained the most 
common feature of a diagnostic examination leading to anti-malarial prescription irrespective of RDT use (observed 
in 96.1, 86.8 and 84.8% of cases, respectively, in 2011 vs. 97.5, 76.6 and 85.7% of cases in 2016). Diagnostic content did 
not vary substantially by RDT result.
Conclusions: Rapid diagnostic tests scale-up has led to a reduction in body temperature measurement. Investiga-
tions are very limited when malaria infection is ruled out as a cause of febrile illness by RDT.
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Background
Health worker access to malaria rapid diagnostic tests 
(RDTs) has increased exponentially over the past dec-
ade. Annual global sales increased from approximately 
120 to 300 million between 2011 and 2014 [1] and dis-
tribution through national malaria control programmes 
increased fourfold over a similar period [2]. Supported 
by investment from international development agencies 
and philanthropic organizations [2], the global scale-up 
of RDTs has been driven by the widespread adoption of 
the 2010 WHO recommendation to test all suspected 
malaria cases prior to administering anti-malarial treat-
ment [3]. The ‘test and treat’ approach represents a step 
change in febrile case management in malaria endemic 
countries where laboratory services to support clini-
cal practice are not routinely available. In contrast with 
former treatment models in which anti-malarial medica-
tions were routinely prescribed to febrile patients based 
on a ‘presumptive’ diagnosis [4], the test and treat pro-
tocol stipulates that anti-malarial medication should only 
be prescribed to patients following parasitological con-
firmation of malaria infection by microscopy or RDT [5]. 
This paradigm shift was driven by the changing epide-
miology of malaria (particularly decreasing transmission 
and increasing heterogeneity), the widespread roll-out 
of more expensive anti-malarial medicines requiring an 
improved specificity of diagnosis [3] and the increasing 
availability and affordability of sufficiently sensitive and 
specific quality-controlled RDTs [6].
Health worker compliance with test and treat proto-
cols, inclusive of RDT use, has been widely investigated 
[7–10]; however, few studies have examined the potential 
impact of RDT scale-up on other aspects of diagnostic 
practice. For example, it is not well understood how bet-
ter RDT access may have altered the depth and content 
of a clinical consultation leading to anti-malarial pre-
scription or the way a clinical consultation for febrile ill-
ness may vary depending on the result of a RDT. These 
are important considerations as RDTs are designed to 
enhance (rather than replace) a comprehensive clini-
cal consultation [5, 11], yet they have been most widely 
distributed in settings where: clinical standards are fre-
quently poor [12]; health workers have little acquired 
experience in the clinical diagnosis and treatment of non-
malarial febrile patients [13]; and where diagnostic tools 
to assist in the identification of fever aetiology in RDT 
negative patients are scarce [14].
This paper examines the impact of RDT scale-up on 
febrile case management in a low- and middle-income 
country (LMIC) setting. The research questions include: 
(1) In what ways does the scale-up of RDTs alter the con-
tent of a diagnostic examination leading to anti-malarial 
prescription, as measured by the number and type of 
diagnostic questions asked and/or procedures per-
formed? And (2) In what ways does diagnostic examina-
tion vary by RDT result, as measured by the number and 
type of diagnostic questions asked and/or procedures 
performed?
Methods
Data were obtained from repeat, countrywide cross-sec-
tional surveys of randomly selected primary healthcare 
facilities conducted as part of a long-term evaluation of 
the Papua New Guinea (PNG) National Malaria Control 
Programme. A full description of the evaluation pro-
gramme, including a detailed description of the health 
facility survey methodology, is presented elsewhere [15].
Study setting
Papua New Guinea is a country of approximately 7.3 mil-
lion people situated in the South West Pacific. Malaria 
endemicity ranges from endemic transmission in lowland 
and coastal settings to unstable transmission with local-
ized epidemics in many Highlands areas [16]. Over 90% 
of the population are considered at risk of malaria infec-
tion [2], although estimated national malaria prevalence 
has fallen to a historic low of 0.9% following substantial 
investment in the National Malaria Control Programme 
[17]. Most primary healthcare services in PNG are deliv-
ered through a network of government- and church-pro-
vided health centres, health sub-centres and aid posts in 
adherence with National Health Service Standards [18]. 
In principle, all cases of uncomplicated malaria should be 
treatable at primary healthcare facilities which are almost 
exclusively staffed by nurses and community health 
workers [19]. PNG implemented ‘test and treat’ malaria 
case management guidelines in late 2011, replacing the 
presumptive treatment guidelines previously in place 
[20]. The percentage of health centres with RDTs in stock 
subsequently increased from 17.5% in 2010 [19] to 90.2% 
in 2012 [21].
Study sample
A stratified approach was used to select health facilities, 
with two health centres or health sub-centres (collec-
tively referred to as health centres in this paper) selected 
from each province using a simple random sampling pro-
cedure. The sampling frame included all health centres 
operational in March 2010 inclusive of government and 
mission administered health facilities (N = 689). Sample 
selection was conducted anew for each survey. All febrile 
patients meeting eligibility criteria attending selected 
health facilities during survey periods were recruited 
consecutively. Patients were considered eligible for par-
ticipation if they were outpatients presenting with febrile 
symptoms, reported a recent history of fever and had not 
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been treated for malaria infection in the past 14 days (to 
exclude ‘treatment review’ cases). Eligible patients were 
identified upon first contact with a health worker or, if 
circumstances allowed, by screening in the waiting area 
prior to first contact with a health worker.
Survey procedure
The three surveys were carried out from June to Novem-
ber in 2011 and 2012 and from February to July in 2016. 
The 2011 survey was completed in the period imme-
diately prior to the introduction of the test and treat 
guidelines, the 2012 and 2016 surveys were completed 
post-implementation. Survey data were collected by 
trained field teams working simultaneously at differ-
ent sites. Members of each survey team spent 3–5 days 
at each participating health centre collecting a range of 
data. This paper reports data obtained from non-par-
ticipant observations of fever or suspected malaria case 
management.
Survey instrument
The non-participant observation was based on a struc-
tured checklist designed to record observed features of 
the clinical case management of patients presenting with 
fever or a recent history of fever. The instrument was 
divided into discrete sections including consultation and 
diagnosis, prescription and treatment counselling. The 
content of each section was informed with input from 
experienced medical- and medical research-profession-
als. The instrument was completed by a trained field 
team member who would silently observe the manage-
ment of patients from the point of initial contact with a 
health professional until service exit or admission onto 
a treatment ward. During the course of this observation, 
the field team member would record whether specified 
actions did or did not occur as well as the outcome of 
specific actions (e.g. whether an RDT was conducted and, 
if yes, the RDT result).
The data presented in this study are largely drawn 
from the ‘diagnosis’ section of this checklist. For the 
2011 and 2012 surveys, this section solely comprised 
16 questions or procedures (listed in Table 2) that were 
considered essential to a thorough diagnostic examina-
tion of suspected malaria. The greater the number of 
questions/procedures completed, the more comprehen-
sive the diagnostic examination (and vice versa). For the 
2016 survey, an additional eight questions or procedures 
were added to this section (listed in Table 5) to account 
for differential diagnosis in the event of a confirmed 
non-malaria febrile illness (NMFI), i.e. additional/alter-
native questions/procedures that a health worker might 
be expected to complete once a malaria infection has 
been ruled out by RDT. A ‘question’ was considered to 
have been completed irrespective of whether an answer 
was obtained via direct health worker enquiry or via 
unprompted patient disclosure.
Data analysis
All data were double entered into DMSys version 5.1 
(Sigma Soft International). Stata/SE version 12 was used 
for descriptive data analysis and for calculating 95% con-
fidence intervals (CIs). The calculation of all CIs was 
adjusted for possible clustering at the health facility level 
using the Stata ‘svy’ command set in which health facili-
ties were defined as the primary sampling unit. Between 
group differences in observed diagnostic practice (by 
survey year or by RDT result), inclusive of the frequency 
with which each diagnostic question/procedure was 
completed and the mean number of questions/proce-
dures completed, were examined by Chi square, t test or 
one-way ANOVA as appropriate. The rank order of diag-
nostic questions/procedures (from most- to least-com-
mon) is also presented to highlight changes over time in 
diagnostic examination leading to anti-malarial prescrip-
tion, or between group differences in diagnostic exami-
nation based on RDT result.
Febrile patients who were admitted or referred else-
where for additional treatment were excluded from 
analysis (i.e. severely ill patients). Analyses examining 
research question two (In what ways does diagnostic 
examination vary by RDT result?) were limited to 2016 
data as this was the only year in which additional diag-
nostic questions that may be asked of confirmed NMFI 
patients were included.
Results
Diagnostic practice leading to anti‑malarial prescription
A total of 1809 observations from 120 health facilities 
were completed across the three survey periods of which 
915 (51%) were prescribed an anti-malarial. Anti-malarial 
prescriptions were provided to 506/582 (87%) patients 
from 43/44 health facilities in 2011, 165/426 (39%) 
patients from 28/37 health facilities in 2012 and 244/801 
(30%) patients from 30/39 health facilities in 2016. 
Selected characteristics of the febrile patients prescribed 
anti-malarials in the three survey samples are presented 
in Table  1. Between group variation in age was statisti-
cally significant (p < 0.005), with fewer participants in the 
< 5 year age band in 2012 and 2016 as compared to 2011.
Table  2 presents the percentage (95% CI) of febrile 
patients prescribed anti-malarials who were observed 
being asked each of nine specified diagnostic questions 
or who were observed receiving each of seven diagnos-
tic procedures. A decrease in frequency was observed 
between 2011 and 2016 on 10/16 questions/procedures; 
seven of which were statistically significant. An increase 
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in frequency was observed for the remaining six ques-
tions/procedures across the same time-period of which 
five were statistically significant. The greatest observed 
decrease was in the percentage of febrile patients who 
had their temperature taken (84–58%). The great-
est observed increase was in the percentage of febrile 
patients receiving a RDT or blood slide (5–78%).
Table  3 presents the respective availability of the 
resources necessary to complete the diagnostic proce-
dures listed in Table 2 in participating health facilities 
per survey year. The availability of resources varied by 
type, although were generally consistent over time. Var-
iation in RDT availability was statistically significant 
(p < 0.005); variations in the availability of other 
resources were not.
The rank order, in terms of most to least observed, of 
the specified diagnostic questions and procedures by 
survey year is presented in Table  2. The five most fre-
quently observed questions or procedures were con-
sistent in 2011 and 2012, although two changes were 
evident by 2016. These included the use of RDT or 
microscopy to diagnose malaria infection (ranked 3rd 
in 2016, up from 7th in 2012 and 14th in 2011) and 
experience of head/body pain (ranked 5th in 2016, up 
from 9th in 2012 and 8th in 2011) at the expense of 
Table 1 Selected participant characteristics by survey year
Characteristic 2011 2012 2016
(N = 506) (N = 165) (N = 244)
n (%) n (%) n (%)
Sex
 Male 242 (48) 79 (48) 130 (53)
 Female 264 (52) 86 (52) 114 (47)
Age (years)
 < 5 273 (55) 63 (38) 77 (32)
 5–14 224 (45) 102 (62) 166 (68)
Table 2 Frequency of diagnostic questions and procedures leading to anti-malarial prescription by survey year
Five most frequently observed questions or procedures are in italics
Questions asked and procedures performed 2011 (N = 506) 2012 (N = 165) 2016 (N = 244) p Rank order
% (95% CI) % (95% CI) % (95% CI) 2011 2012 2016
Questions
 Current use of any medication 26.1 (17.9, 36.4) 27.9 (19.4, 38.3) 24.2 (16.4, 34.2) 0.698 10 11 12
 Concurrent illness/existing condition 48.6 (38.8, 58.5) 44.9 (35.7, 54.3) 34.0 (25.1, 44.2) < 0.005 9 10 10
 Experience of fever 96.1 (92.8, 97.9) 89.7 (74.3, 96.3) 97.5 (94.4, 99.0) < 0.005 1 1 1
 Experience of cough 86.8 (82.7, 90.0) 80.0 (69.3, 87.7) 76.6 (64.3, 85.7) < 0.005 2 3 4
 Experience of head/body ache/pain 58.5 (51.7, 65.0) 56.4 (41.0, 70.6) 64.3 (53.3, 74.1) 0.197 8 9 5
 Experience of nausea/vomiting 65.6 (59.5, 71.3) 63.0 (51.5, 73.2) 61.5 (51.3, 70.8) 0.519 6 6 6
 Experience of diarrhoea 65.4 (57.9, 72.3) 58.8 (46.7, 69.9) 57.8 (46.1, 68.7) 0.080 7 8 9
 Experience of chills 20.0 (13.9, 27.8) 27.3 (19.4, 36.9) 32.8 (22.9, 33.9) < 0.005 11 12 11
 Duration of current symptoms 84.8 (79.8, 88.7) 77.0 (61.6, 87.5) 85.7 (76.2, 91.8) 0.038 3 4 2
Procedure
 Body temperature measured 84.4 (75.9, 90.3) 81.8 (63.3, 92.2) 58.2 (40.1, 74.3) < 0.005 4 2 8
 Body weight measured 77.7 (69.2, 84.3) 73.9 (58.1, 85.3) 60.3 (45.7, 73.2) < 0.005 5 5 7
 Blood pressure measured 0.6 (0.2, 1.8) 6.1 (2.6, 13.3) 0.8 (0.2, 3.4) < 0.005 16 15 15
 Abdomen palpated 14.0 (10.1, 19.1) 12.1 (7.0, 20.1) 6.6 (2.5, 15.9) 0.011 13 13 13
 Eyes examined 15.2 (10.4, 21.7) 7.9 (4.2, 14.2) 3.7 (1.1, 12.1) < 0.005 12 14 14
 Palms examined 1.6 (0.5, 4.5) 3.6 (1.4, 9.3) 0 (–) 0.013 15 16 16
 Malaria RDT/blood slide completed 5.3 (3.0, 9.4) 60.6 (34.4, 81.9) 77.9 (58.0, 90.0) < 0.005 14 7 3
Table 3 Number and  percent of  health facilities 
with specified resources available
Health facilities from which one or more of the clinical observations took place
Characteristic 2011 2012 2016
(N = 44) (N = 37) (N = 39)
n (%) n (%) n (%)
Thermometer 42 (95) 37 (100) 38 (97)
Bodyweight scale 44 (100) 35 (95) 37 (95)
Blood pressure apparatus 38 (86) 26 (70) 32 (82)
RDTs 10 (23) 33 (89) 28 (70)
Microscopy 5 (11) 1 (3) 3 (8)
Anti-malarials 44 (100) 37 (100) 39 (100)
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measuring body weight and temperature (ranked 7th 
and 8th, respectively, in 2016).
Minor variations in the mean number of questions (5.5, 
5.2, 5.3), procedures (2.0, 2.5, 2.1) and combined ques-
tions/procedures (7.5, 7.7, 7.4) asked or performed were 
evident between 2011, 2012 and 2016 (Fig.  1), although 
only the variation in procedures was statistically signifi-
cant (p < 0.005).
Differential diagnosis
Rapid diagnostic tests status was available for 781/801 
(98%) of participants from all 39 health facilities included 
in the 2016 survey, of whom 210/781 (27%) did not 
receive an RDT, 405/781 (52%) received an RDT and 
tested negative for malaria infection and 166/781 (21%) 
received an RDT and tested positive for malaria infec-
tion. Selected demographic and prescription data for 
the three diagnostic groups are presented in Table  4. 
Between group variations in sex ratio were not statisti-
cally significant, but between group variations in age and 
in the proportions prescribed anti-malarials, antibiotics 
and analgesics were (all p < 0.005). The variations in the 
proportions prescribed anti-malarials, antibiotics and 
analgesics remained statistically significant when just 
comparing the RDT negative versus RDT positive sub-
groups (all p < 0.005), although sex and age differences 
were not.
Table 5 compares those febrile patients who tested pos-
itive for malaria infection by RDT with those who tested 
negative on a broader range of diagnostic questions and 
procedures. Figures and percentages for those febrile 
patients who were not provided a RDT are also presented 
to afford a further comparison, although this sub-group 
was excluded from further analysis. Overall, 12/23 ques-
tions/procedures were more frequently observed among 
RDT positive patients as compared to RDT negative 
patients, of which three were statistically significant. 
Eleven questions/procedures were more frequently 
observed among patients who tested negative for malaria 
infection, three of which were statistically significant. The 
greatest observed difference between the RDT negative 
and positive patient groups was in the percentage asked 
whether they had a concurrent illness or existing condi-
tion (18.9% in RDT− patients vs. 33.7% in RDT+).
The rank order, in terms of most to least observed, of 
the specified diagnostic questions and procedures by 
RDT result is presented in Table  5. Four out of the five 
most frequently observed questions or procedures were 
consistent across both RDT negative and RDT positive 
patient groups, including: experience of fever, experience 
of cough, experience of head or body pain and duration 
of current symptoms.
No statistically significant differences in the mean 
number of questions (5.7 vs. 5.8), procedures (2.4 vs. 2.5) 
or combined questions/procedures (8.1 vs. 8.3) asked or 
performed were observed between RDT− and RDT+ 
groups (Fig. 2). The mean number of questions asked was 
greater for febrile patients not tested for malaria infec-
tion (6.4), although the mean number of procedures 
completed was lower (1.4) as was the overall number of 
combined questions/procedures (7.8).
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Fig. 1 Mean number (standard deviation) of diagnostic questions, procedures and combined questions/procedures observed by survey year
Table 4 Participant sex, age and  prescription by  RDT 
result, 2016 sample only
a  Patients may have been prescribed more than one medication
Characteristic Not tested RDT− RDT+
(N = 210) (N = 405) (N = 166)
n (%) n (%) n (%)
Sex
 Male 111 (53) 200 (49) 73 (44)
 Female 99 (47) 205 (51) 93 (56)
Age (years)
 < 5 104 (50) 160 (40) 52 (32)
 5+ 196 (50) 245 (60) 114 (68)
Prescriptiona
 Anti-malarial 54 (26) 23 (6) 166 (100)
 Antibiotic 160 (76) 337 (83) 43 (26)
 Analgesic 125 (60) 305 (75) 98 (59)
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Discussion
This study found that the mean number of diagnostic 
questions and procedures asked or performed, leading to 
anti-malarial prescription, remained consistent pre- and 
post-RDT scale-up. Thus, the widespread introduction of 
an additional diagnostic procedure (i.e. the RDT) did not 
increase the content of diagnostic examination. Rather, 
alterations in diagnostic content were evident with the 
RDT replacing body temperature as the most commonly 
employed diagnostic procedure (the former increasing in 
frequency from 5.3 to 77.9%, the latter decreasing from 
84.6 to 58.2%). Measuring bodyweight also became less 
Table 5 Frequency of diagnostic questions and procedures by RDT result, 2016 sample only
Five most frequently observed questions or procedures are in italics
a  Based on Chi square analysis of ‘RDT−’ vs. ‘RDT+’ sub-groups only (i.e. data presented in the ‘not tested’ column were excluded from this test)
Questions asked and procedures performed Not tested (N = 210) RDT− (N = 405) RDT+ (N = 166) pa Rank order
% (95% CI) % (95% CI) % (95% CI) RDT− RDT+
Questions
 Current use of any medication 23.3 (14.8, 34.8) 16.3 (9.4, 26.9) 24.1 (15.2, 36.0) 0.029 12 11
 Concurrent illness/existing conditions 35.2 (24.8, 47.3) 18.9 (14.1, 24.9) 33.7 (23.5, 45.8) < 0.005 11 9
 Experience of convulsions 3.8 (1.3, 11.1) 2.6 (1.1, 6.0) 3.6 (1.7, 7.7) 0.515 19 19
 Experience of drowsiness/unconsciousness 7.7 (4.3, 13.3) 9.7 (5.9, 15.6) 8.4 (4.2, 16.3) 0.631 15 15
 Experience of fever 98.6 (95.9, 99.5) 97.9 (96.1, 98.9) 97.6 (94.4, 99.0) 0.834 1 1
 Experience of cough 87.1 (70.9, 95.0) 84.4 (77.7, 89.3) 78.3 (68.0, 86.0) 0.079 3 3
 Experience of breathing difficulties 40.0 (24.8, 57.4) 31.5 (22.2, 42.6) 21.1 (12.1, 34.2) 0.012 9 12
 Experience of head/body pain 53.3 (44.1, 62.3) 57.9 (50.0, 65.4) 65.1 (51.7, 76.4) 0.112 5 4
 Experience of ear ache 14.8 (7.9, 26.2) 10.9 (6.6, 17.6) 11.5 (6.4, 19.8) 0.857 14 13
 Experience of nausea/vomiting 59.1 (45.3, 71.5) 54.4 (45.6, 62.9) 59.6 (40.1, 68.5) 0.247 7 7=
 Experience of diarrhoea 61.4 (46.7, 74.3) 55.3 (46.7, 63.7) 60.2 (48.5, 70.9) 0.278 6 6
 Experience of chills 32.4 (21.2, 46.1) 23.2 (17.7, 29.7) 28.3 (19.5, 39.2) 0.192 10 10
 Ability to drink/breastfeed 30.0 (19.0, 45.0) 15.4 (10.1, 22.8) 9.0 (4.7, 16.6) 0.043 13 14
 Measles/spots in past 3 months 4.3 (2.4, 7.6) 2.4 (0.9, 6.3) 0 (–) 0.045 20= 22=
 Duration of current symptoms 89.5 (81.9, 94.2) 85.3 (76.3, 91.4) 84.3 (73.6, 91.2) 0.758 2 2
Procedure
 Body temperature measured 59.1 (41.2, 74.8) 67.9 (49.2, 82.1) 59.6 (39.7, 76.9) 0.059 4 7=
 Body weight measured 45.2 (30.9, 60.5) 53.0 (41.5, 64.1) 63.9 (45.1, 79.1) 0.016 8 5
 Blood pressure measured 3.8 (0.8, 16.7) 0.2 (0.1, 1.9) 1.2 (0.3, 5.0) 0.137 23 20=
 Abdomen palpated 6.7 (3.1, 13.8) 3.6 (1.6, 7.5) 7.2 (2.1, 22.3) 0.055 18 17
 Eyes examined 11.0 (5.4, 21.1) 6.4 (3.3, 11.9) 4.2 (0.9, 18.2) 0.311 16 18
 Palms examined 1.9 (0.4, 9.0) 1.9 (0.8, 4.7) 0 (–) 0.074 22 22=
 Respiratory rate measured 16.7 (7.1, 34.2) 4.3 (2.2, 8.2) 7.9 (2.5, 22.8) 0.074 17 16
 Other diagnostic test (or referral) 1.4 (0.3, 6.1) 2.4 (0.9, 6.3) 1.2 (0.2, 7.5) 0.194 20= 20=
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Fig. 2 Mean number (standard deviation) of diagnostic questions, procedures and combined questions/procedures observed by RDT result (2016 
only)
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common across the three survey periods, although a 
greater proportion of participants were aged over 5 years 
in the latter two surveys (and were, therefore, perhaps 
less likely to be weighed) which may have accounted for 
this result. Verbal questioning, especially experience of 
fever, cough and duration of symptoms, remained the 
most common feature of a diagnostic examination lead-
ing to anti-malarial prescription irrespective of RDT use. 
Content-related changes to diagnostic examination fol-
lowing RDT scale-up, therefore, appear to be relatively 
minimal and primarily limited to a reduction in the fre-
quency of body temperature measurement.
Similarly, the study found that diagnostic content 
did not vary substantially by RDT result (RDT− vs. 
RDT+). The mean number of diagnostic questions and 
procedures asked or performed were markedly simi-
lar irrespective of test result and there were only minor 
between-group variations in the frequency with which 
each of 23 specified diagnostic questions or procedures 
were observed. In addition, febrile patients not tested 
for malaria infection by RDT in the 2016 survey were no 
more likely to have their body temperature measured as 
compared to those who were tested by RDT, suggesting a 
‘culture shift’ away from routine body temperature meas-
urement in cases of febrile illness may have taken place.
The study findings do not challenge the benefit of 
RDT scale-up to febrile patients prescribed anti-malar-
ials based on a confirmed malaria infection. The WHO 
approved RDTs widely used in PNG have sound met-
rics [22], RDT-based malaria case management has 
been proven effective in PNG [23] and national survey 
data indicate artemisinin combination therapies (ACTs) 
are widely prescribed to confirmed malaria cases [21]. 
Whether body temperature is measured or not, a positive 
RDT result, if followed up by an appropriate, ACT-based 
anti-malarial prescription, is likely to result in a more 
cost-efficient and effective treatment than that provided 
under the former presumptive model of malaria case 
management.
Benefits of RDT scale-up in NMFI cases are less clear. 
Febrile patients who test negative for malaria infection 
by RDT are less likely to receive an unnecessary anti-
malarial medication as compared to the near universal 
prescription of anti-malarials under the former presump-
tive approach [24]. However, many NMFI patients are 
not receiving a more intensive or varied diagnostic exam-
ination (as may be expected following ‘the ruling out’ 
of malaria infection by RDT) and the rate of antibiotic 
prescription (83%) is alarmingly high. A recent study of 
health worker adherence to national prescription guide-
lines in PNG found antibiotics were overprescribed in 
41% of over 3000 NMFI cases across 10 specified illnesses 
[25] and international evidence suggests antibiotic over 
prescription in NMFI is a growing concern [26]. Ensuring 
appropriate management of NMFI is increasingly impor-
tant in PNG as malaria case positivity rates have dropped 
(often well) below fifty percent [27] in response to an 
effective national malaria control programme [17].
Further inadequacies in primary healthcare work-
ers’ diagnostic practice were evident pre- and post RDT 
scale-up. Contextually appropriate and accessible diag-
nostic procedures such as abdomen palpation were rarely 
conducted nor were common ‘danger signs’ routinely 
investigated. A statistically significant reduction in the 
frequency with which concurrent illnesses or existing 
conditions were queried among patients prescribed anti-
malarials was also observed across time, suggesting the 
confirmation of malaria by RDT may discourage health 
workers from exploring other/existing causes of illness. 
When one also considers the limited laboratory support 
for the diagnosis of NMFI in PNG and poor treatment 
counselling practices previously documented [21, 24], 
then it is difficult not to conclude that the level of train-
ing, support and supervision provided to primary health-
care workers to support accurate diagnosis and treatment 
of febrile illness is insufficient.
The reported study was not without limitation. Par-
ticipating clinicians were aware that they were being 
observed and may have altered their clinical practice 
accordingly. The expected effect of any such bias would 
be towards perceived ‘better’ practice. The analysis of 
diagnostic practice leading to anti-malarial prescription 
was limited to diagnostic features considered important 
or essential to a malaria diagnosis and did not account 
for other diagnostic questions or procedures that may 
have been asked or completed. The sequence with which 
specified diagnostic questions/procedures were com-
pleted was not recorded. However, in practice, all/most 
questions were typically asked prior to completing a RDT 
or obtaining the RDT result. Finally, the sample did not 
include any observations from the lowest level of pri-
mary healthcare service provision in PNG, the aid-post 
(typically staffed by a single health worker in remote 
locations), and so the reported findings should not be 
considered reflective of diagnostic practice at this level.
The study findings and implications presented in this 
paper are unlikely to be unique to PNG. Challenges 
related to health worker practice, training and supervi-
sion in resource poor settings [12] are common to many 
malaria endemic countries. Intensive investment in 
vertical disease control programmes, such as occurred 
in PNG, can potentially undermine health systems 
strengthening [28, 29]. The few studies that have exam-
ined the impact of investment in malaria control pro-
grammes on the management of febrile illness at a 
broader level (i.e. analyses not restricted to confirmed 
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malaria cases only) have identified reduced or sub-
optimal systems effectiveness, despite improvements 
in malaria case management [26, 30, 31]. Findings 
from this study do not suggest febrile case manage-
ment has worsened in PNG as a result of RDT scale-up; 
however, they do suggest that the implications of RDT 
scale-up on wider febrile case management were not 
as well considered as they could have been. Arguably, 
the dedicated training resources provided in support of 
RDT scale-up in PNG, such as multi-day ‘skills’ work-
shops for healthcare workers and the development and 
dissemination of programme specific job-aides [32], 
presented an opportunity to strengthen diagnostic, pre-
scription and counselling practices across a board array 
of febrile illnesses. However, the training focus was 
restricted to malaria case management and, as such, the 
opportunity for broader health systems strengthening 
was lost.
Conclusions
Primary healthcare workers in PNG are using RDTs 
in their diagnostic examination of febrile illnesses at a 
substantially higher rate following nationwide scale-up, 
although the level of assessment remains similar as com-
plementary diagnostic procedures are used less often. In 
those cases where malaria infection has been ruled out as 
a cause of febrile illness by RDT, few additional or alter-
native questions or procedures are undertaken beyond 
those routinely completed anyway. The standard of diag-
nostic examination remains sub-optimal irrespective of 
the cause of febrile illness. Health worker performance 
may be enhanced by providing training or support ini-
tiatives that pertain more broadly to febrile case manage-
ment as opposed to malaria-specific case management.
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